Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: J Bone Miner Res. 2016 Feb 15;31(6):1137–1145. doi: 10.1002/jbmr.2779

Table 1.

Demographic and Biochemical Characteristics of the Study Population

Characteristic N =1888
Age (years) 64.1 (9.2)
Female (no. [%]) 1029 (54.5)
Race/ethnicity (no. [%])
 White 616 (32.6)
 Chinese-American 170 (9.0)
 African-American 731 (38.7)
 Hispanic 371 (19.7)
BMI (kg/m2) 29.7 (5.7)
Systolic blood pressure (mmHg) 133.8 (21.4)
Diastolic blood pressure (mmHg) 73.9 (10.5)
Antihypertensive medications (no. [%])
 Thiazide 518 (27.4)
 Loop diuretic 82 (4.3)
 Calcium-channel blocker 637 (33.7)
 Dihydropyridine CCB 448 (23.7)
 Non-dihydropyridine CCB 189 (10)
 Beta-blocker 472 (25)
 RAAS-inhibitor 891 (47.2)
 Alpha-blocker 194 (10.3)
No. of antihypertensive medications
 1 1167 (61.8)
 2 523 (27.7)
 3 158 (8.4)
 3+ 26 (1.4)
Education (highest level completed) (no. [%])
 No schooling to some high school 353 (18.8)
 Completed high school to some college 690 (36.7)
 Completed post-secondary school degree 838 (44.6)
Smoking status (no. [%])
 Never smoker 925 (49.2)
 Former 741 (39.4)
 Current 215 (11.4)
Physical activity (mean hr/d) 12.4 (6.1)
Diabetes status (no. [%])
 Normal 1178 (32.4)
 Impaired fasting glucose 308 (16.3)
 Diabetes 402 (21.3)
PTH (pg/mL) 46.1 (19.3)
eGFR (mL/min/1.73m2) 79.9 (13.0)
Serum calcium (mg/dL) 9.65 (0.38)
Urine calcium/Cr ratio (mg/g) 0.09 (0.07)
Serum phosphate (mg/dL) 3.6 (0.5)
Urine phosphate/Cr ratio (mg/g) 0.48 (0.2)
Annualized 25OHD (ng/mL) 24.6 (11.2)
FGF23 (pg/mL) 40.4 (18.9)

Values are mean (SD) unless otherwise specified.

BMI =body mass index; CCB =calcium-channel blocker; PTH =parathyroid hormone; eGFR =estimated glomerular filtration rate; Cr =creatinine; 25OHD =25-hydroxyvitamin D; FGF-23 =fibroblast growth factor 23.